Showing results (61-70 of 231) with videos related to
Sort By:
Pageof 24
Therapeutic Advances in Medical Oncology|October 31, 2019
The effect of CELLFOOD<sup>TM</sup> on radiotherapy or combined chemoradiotherapy: preclinical evidenceBarbara Nuvoli, Bruno Amadio, Giancarlo Cortese, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 19, 2013
Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patientsCinzia Fabbri, Riccardo Galassi, Andrea Moretti, et al.Frontiers in Oncology|March 21, 2022
Immune Checkpoint Inhibitor-Induced Central Diabetes Insipidus: Looking for the Needle in the Haystack or a Very Rare Side-Effect to Promptly Diagnose?Agnese Barnabei, Lidia Strigari, Andrea Corsello, et al.Journal of Experimental & Clinical Cancer Research : CR|December 17, 2013
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical controlMaria Grazia Petrongari, Valeria Landoni, Biancamaria Saracino, et al.Zeitschrift Fur Medizinische Physik|April 8, 2023
Heterogeneity of absorbed dose distribution in kidney tissues and dose-response modelling of nephrotoxicity in radiopharmaceutical therapy with beta-particle emitters: A reviewClarita Saldarriaga Vargas, Michelle Andersson, Céline Bouvier-Capely, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 6, 2020
Absorbed dose measurements from a <sup>90</sup>Y radionuclide liquid solution using LiF:Mg,Cu,P thermoluminescent dosimetersMarco D'Arienzo, Maria Pimpinella, Vanessa De Coste, et al.Frontiers in Endocrinology|April 7, 2022
Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging TaskAgnese Barnabei, Lidia Strigari, Andrea Corsello, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 19, 2009
Hypofractionated Conformal Radiotherapy (HCRT) for primary and metastatic lung cancers with small dimension : efficacy and toxicityMaria Alessandra Mirri, Giorgio Arcangeli, Marcello Benassi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2025
Efficacy and Safety of Epidermal Radionuclide Therapy with <sup>188</sup>Re Resin in Patients with Nonmelanoma Skin Cancers: Long-Term Data from a Single CenterPaolo Castellucci, Carlotta Baraldi, Luigia Vetrone, et al.International Journal of Radiation Oncology, Biology, Physics|June 9, 2012
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trialValérie Fonteyne, Guy Soete, Stefano Arcangeli, et al.Pageof 24